Status:

COMPLETED

Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis

Lead Sponsor:

Sun Yat-sen University

Conditions:

Ankylosing Spondylitis

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

To assess the efficacy and safety of loxoprofen sodium hydrogel patch (LX-P) versus loxoprofen sodium tablet (LX-T) in patients with active ankylosing spondylitis(AS). The trial includes 70 patients w...

Detailed Description

This is a 4-week randomized, open-label trial to investigate the efficacy and safety of loxoprofen sodium hydrogel patch (LX-P) versus loxoprofen sodium tablet (LX-T) in patients with active ankylosin...

Eligibility Criteria

Inclusion

  • 18 to 65 years
  • Meet 1984 modified New York criteria for AS
  • The Bath AS Disease Activity Index (BASDAI) ≥4 on a 0-10-cm visual analog scale or the Ankylosing Spondylitis Disease Activity Score using the C-reactive protein level (ASDAS-CRP) ≥1.3
  • NSAIDs washout period of at least 5 days prior to randomization
  • DMARDs washout period of at least 4 weeks prior to randomization
  • Corticosteroids washout period of at least 4 weeks prior to randomization
  • Biological agents washout period of at least 3 months prior to randomization.

Exclusion

  • Peptic ulcer
  • Unstable cardiac diseases
  • Abnormal hepatic function with an elevation of alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥ 2.5 times of upper normal limits
  • Abnormal renal function with creatinine more than upper normal limit
  • Hematologic disorders
  • Psychosis
  • Malignancy
  • Allergic to LX drug.

Key Trial Info

Start Date :

May 25 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 10 2015

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT03800797

Start Date

May 25 2015

End Date

December 10 2015

Last Update

January 11 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China